BIOCENTECH APS: Financial statements 2025
CVR: 25437470
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
BIOCENTECH APS (CVR 25437470) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -13,000 and a net result of DKK -14,669 compared with DKK -19,363 the year before. Equity in the 2025 report amounted to DKK -61,305.
- Gross Profit
- DKK -13,000
- Profit/Loss
- DKK -14,669
- Equity
- DKK -61,305
- Total Assets
- DKK 61,082
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -13 t. | -15 t. | -61 t. | 0 |
| 2024 | - | -18 t. | -19 t. | -47 t. | - |
| 2023 | - | -15 t. | -16 t. | -27 t. | - |
| 2022 | - | -5 t. | -6 t. | 3 t. | - |
| 2021 | - | -6 t. | -7 t. | 9 t. | - |
Official annual report
How creditworthy is BIOCENTECH APS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
BIOCENTECH APS has published its annual report for 2024. Gross profit came to DKK -17,690, and the net result was DKK -19,363.
About BIOCENTECH APS
BIOCENTECH APS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2000. The company is registered under the industry Fremstilling af andre maskiner til specielle formål i.a.n.. The management consists of Aleksander Nærvig. The company is owned by NÆRVIG GROUP ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -13,000 and a net result of DKK -14,669 compared with DKK -19,363 the year before. Equity in the 2025 report amounted to DKK -61,305.